ALT 0.00% 0.1¢ analytica limited

wiseowl 8.2c valuation

  1. 23,919 Posts.
    lightbulb Created with Sketch. 752
    WiseOwl research report out with spec buy up to 8.2c

    http://www.analyticamedical.com/downloads/2012/20121220-WiseOwl-Analytica.pdf

    Expect revenues in Q3 of 2013 and value the Brazillian deal to be worth $3M per annum.

    Would make ALT cashflow positive.

    Great news
 
watchlist Created with Sketch. Add ALT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.